Why Choose SimiTree for Home Health M&A?
- Gain Industry-Specific Expertise: Receive insights from a team that deeply understands home health regulations, reimbursement models, and operational challenges. Our team has, on average, 20 years of experience in home health, home care, and hospice.
- Receive Comprehensive Due Diligence: Receive comprehensive assessments of clinical quality and billing compliance, financial performance, and operations, specifically tailored to each home health agency.
Our Comprehensive M&A Services for Home Health
- Quality of Earnings/Financial Due Diligence
- Validate and analyze financial performance.
- Examine billing practices and key operational metrics including key PDGM metrics, payer mix, census, direct costs visit, and referral trends.
- Provide detailed reports on financial performance, company trends, and benchmarking comparisons.
- Clinical Compliance Due Diligence
- Assess risk factors unique to home health, including OASIS accuracy and care plan compliance.
- Review clinical and billing documentation, assess potential reimbursement risk, and gain insight into operational processes as they relate to payer conditions of participation and conditions of payment.
- Business Valuations
- Provide accurate valuations considering factors like PDGM impact and star ratings.
- Look beyond capital structure to assess company management, operational details, and market activity.
- Market Referral Analysis
- Evaluate referral patterns and growth potential in target markets.
- Identify untapped opportunities and assess brand loyalty in seemingly saturated markets.
- Post-Close Integration
- Ensure smooth transitions, focusing on care continuity and staff retention.
- Provide interim management, technology consulting, and operational support.
- Home Health Value Based Purchasing (HHVBP) Analysis
- VBP Assessment: Comprehensive evaluation of performance metrics and trending analysis
- Data Analysis: Data-driven insights into target areas for improvement
- Performance Improvement Projections: Forecasted scores for each individual metric including projected payment adjustments
SimiTree’s Home Health M&A Differentiators
-
PDGM Impact Assessment
We evaluate financial implications of the Patient-Driven Groupings Model.
-
Star Rating Analysis
We assess quality measures and their impact on business value and growth.
-
Regulatory Compliance
We address complex federal and state regulations for home health agencies.
-
Value-Based Purchasing (VBP) Analysis
We assess performance in VBP and strategies for success in this reimbursement model.
SimiTree’s Unique Approach to Home Health M&A
-
Forward-Looking Reimbursement Analysis: Our team provides insights into upcoming changes in reimbursement structures, helping you make informed decisions about long-term value.
-
Operational Efficiency Evaluation: We assess key operational drivers that impact reimbursement, such as visit utilization, care coordination, and patient outcomes.
Partner with SimiTree for Your Home Health M&A
SimiTree serves strategic buyers, private equity firms, not-for-profit organizations, and individual investors.
Contact us to leverage our industry-leading insights and maximize your transaction value.
Frequently Asked Questions
-
SimiTree combines deep industry knowledge with comprehensive due diligence services, offering unique insights into a complex and ever-changing industry.
-
We analyze historical performance under PDGM, evaluate the agency’s adaptation to the model, and project future performance based on clinical and operational factors.
-
Star ratings are crucial in valuations as they impact referrals and reimbursement. We assess current ratings, identify improvement opportunities, and evaluate their impact on future growth.
-
We offer comprehensive post-close integration services, including interim management, technology consulting, and operational support to ensure a smooth transition and maximize value.
-
Yes, our expert team provides detailed valuations considering factors beyond just market trends like PDGM impact, market position, and growth potential.